Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15 Marty ChaplinRebecca BresnahanPinki Munot Review Article Open access 20 September 2023 Pages: 863 - 875
Characteristics and Quality Appraisal of the Economic Evaluations Done in Ethiopia: A Systematic Review Bereket Bahiru TeferaDesalegn Getnet DemsieZewdu Yilma Systematic Review Open access 25 August 2023 Pages: 877 - 886
Cost-Effectiveness of Non-pharmacological Interventions for Mild Cognitive Impairment and Dementia: A Systematic Review of Economic Evaluations and a Review of Reviews Gillian EaglestoneEvdoxia GkaintatziPaul McCrone Systematic Review Open access 25 September 2023 Pages: 887 - 914
Trade-Offs between Vaccine Effectiveness and Vaccine Safety: Personal versus Policy Decisions Semra OzdemirSean NgEric Andrew Finkelstein Original Research Article Open access 11 October 2023 Pages: 915 - 926
Hospital Resource Utilization and Costs in Patients with Heart Failure in France Frank ChemouniTiffany Chihiro NishikawaDeborah Ittah Original Research Article Open access 15 September 2023 Pages: 927 - 940
Retrospective Comparison of Survival Projections for CAR T-Cell Therapies in Large B-Cell Lymphoma Elisabeth F. P. PeterseElisabeth J. M. Verburg-BaltussenSven L. Klijn Original Research Article Open access 31 August 2023 Pages: 941 - 950
Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data Luis Phillipe Nagem LopesAlexander ItriaLuciane Cruz Lopes Original Research Article Open access 14 September 2023 Pages: 951 - 961
The EQ-5D-3L Valuation Study in Pakistan Madeeha MalikNing Yan GuFredrick Dermawan Purba Original Research Article Open access 13 September 2023 Pages: 963 - 974
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States Ahmed SalemElizabeth M. LaChristopher F. Carpenter Original Research Article Open access 02 November 2023 Pages: 975 - 985
Estimating Cumulative Health Care Costs of Childhood and Adolescence Autism Spectrum Disorder in Ontario, Canada: A Population-Based Incident Cohort Study Claire de OliveiraBryan Tanner Original Research Article Open access 27 September 2023 Pages: 987 - 995
Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada Reka E. PatakyStirling BryanDean A. Regier Original Research Article Open access 11 October 2023 Pages: 997 - 1006
Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality L. A. de JongX. LiT. L. Feenstra Protocol Open access 22 August 2023 Pages: 1007 - 1013
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15 Marty ChaplinRebecca BresnahanPinki Munot Correction Open access 05 December 2023 Pages: 1015 - 1015